Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Marit D Moen"'
Publikováno v:
Drugs & Therapy Perspectives. 28:1-5
Monotherapy with intravenous vinflunine is indicated for the treatment of adults with advanced or metastatic transitional cell carcinoma of the urothelium after failure of a prior platinum-containing regimen. In this patient population, vinflunine ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86258b4942e2fef7bca8d6477e7487dc
https://doi.org/10.2165/11208720-000000000-00000
https://doi.org/10.2165/11208720-000000000-00000
Autor:
Marit D Moen
Publikováno v:
Drugs. 70:181-189
Bevacizumab is a recombinant humanized monoclonal IgG(1) antibody that binds to human vascular endothelial growth factor and inhibits angiogenesis and hence tumour growth. It is available in the US and other countries for the treatment of several typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e85a029714c30af3931ce2eefafbb5
https://doi.org/10.2165/11203890-000000000-00000
https://doi.org/10.2165/11203890-000000000-00000
Autor:
Marit D Moen
Publikováno v:
Drugs. 69:2621-2632
▴ Topical diclofenac solution (Pennsaid®) is a liquid formulation containing the NSAID diclofenac sodium (1.5% w/w). The solution base contains 45% w/w dimethyl sulfoxide (DMSO) to enhance the absorption of diclofenac through the skin. Topical dic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99589ef9db9ce87089056eb378bab689
https://doi.org/10.2165/11202850-000000000-00000
https://doi.org/10.2165/11202850-000000000-00000
Autor:
Susan J Keam, Marit D Moen
Publikováno v:
CNS Drugs. 23:1057-1083
Dexmethylphenidate extended release (XR) [Focalin® XR] is a CNS stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in patients aged ≥6 years. Dexmethylphenidate contains the d-threo- enantiomer of methylphenid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcc789a0d1434deddc2083452ec34cd7
https://doi.org/10.2165/11201140-000000000-00000
https://doi.org/10.2165/11201140-000000000-00000
Autor:
Marit D Moen, Gillian M. Keating
Publikováno v:
Drugs. 68:2059-2083
Raloxifene (Evista) is a second-generation selective estrogen receptor modulator (SERM) that functions as an estrogen antagonist on breast and uterine tissues, and an estrogen agonist on bone. It is available in many countries worldwide for the treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115c77bf50787dd70cb0ca16f4eb291a
https://doi.org/10.2165/00003495-200868140-00008
https://doi.org/10.2165/00003495-200868140-00008
Autor:
Marit D, Moen, Gillian M, Keating
Publikováno v:
American Journal of Cardiovascular Drugs. 8:341-348
*Conivaptan is an arginine vasopressin V1A and V2 receptor antagonist. The intravenous formulation is approved in the US for use in the treatment of euvolemic and hypervolemic hyponatremia. Conivaptan produces a dose-dependent electrolyte-sparing aqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67931e293f31ed1e045bba164520ad83
https://doi.org/10.2165/00129784-200808050-00006
https://doi.org/10.2165/00129784-200808050-00006
Autor:
Lesley J. Scott, Marit D Moen
Publikováno v:
BioDrugs. 21:205-208
▴ Full-length parathyroid hormone (PTH) 1–84 is a recombinant version of human PTH. It is approved in the EU for the treatment of postmenopausal women with osteoporosis who have a high risk of fractures. Once-daily subcutaneous administration of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f6352afdc88014c6e0a71300cfb9f19
https://doi.org/10.2165/00063030-200721030-00009
https://doi.org/10.2165/00063030-200721030-00009
Autor:
Antona J. Wagstaff, Marit D Moen
Publikováno v:
Drugs. 66:1389-1409
Nebivolol is a third-generation beta-adrenoceptor antagonist. It differs from other beta-adrenoceptor antagonists as it combines highly selective beta(1)-adrenoceptor antagonist properties with nitric oxide-mediated vasodilatory actions and beneficia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df74283aff8e048e80fcc51e10eeee7
https://doi.org/10.2165/00003495-200666100-00007
https://doi.org/10.2165/00003495-200666100-00007
Autor:
Greg L. Plosker, Marit D Moen
Publikováno v:
Drugs & Aging. 23:843-846
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faa5df3ce8ea47a8121b88cfeb3ac080
https://doi.org/10.2165/00002512-200623100-00007
https://doi.org/10.2165/00002512-200623100-00007
Autor:
Marit D Moen, Gillian M. Keating
Publikováno v:
Drugs. 66:883-890
Sumatriptan is a serotonin 5-HT(1B/1D) receptor agonist that is used for the acute treatment of migraine attacks. A new fast-disintegrating/rapid-release sumatriptan tablet (sumatriptan FDT/RRT) has been developed with the goal of speeding absorption
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5504a56121ee099d0b4a1c47e8c2fc87
https://doi.org/10.2165/00003495-200666060-00018
https://doi.org/10.2165/00003495-200666060-00018